GUANGZHOU, China, June 03, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Restricted (NASDAQ: BNR and LSE: BNR, the Firm or Burning Rock), an organization centered on the applying of subsequent technology sequencing (NGS) expertise within the discipline of precision oncology, immediately introduced that it has obtained a notification letter from the employees of the Itemizing {Qualifications} Division of the Nasdaq Inventory Market LLC (NASDAQ) on Might 30, 2024, informing the Firm that it has regained compliance with the minimal bid worth requirement set forth in Nasdaq Itemizing Rule 5450(a)(1) (the Minimal Bid Worth Requirement).
As beforehand introduced, on December 29, 2023, the Firm was notified by NASDAQ that it was not in compliance with the Minimal Bid Worth Requirement as a result of the closing bid worth for the Firm’s American depositary shares (the ADSs) was beneath the minimal bid worth of $1.00 per share for 30 consecutive enterprise days. To regain compliance, the Firm was required to keep up a minimal closing bid worth of $1.00 per share for no less than 10 consecutive enterprise days. With a view to regain compliance with the Minimal Bid Worth Requirement, the Firm modified the ratio of its ADSs representing its Class A peculiar shares from one (1) ADS representing one (1) Class A peculiar share to 1 (1) ADS representing ten (10) Class A peculiar shares. The change grew to become efficient on Might 15, 2024.
On Might 30, 2023, NASDAQ supplied affirmation to the Firm that for the final 10 consecutive enterprise days, from Might 15, 2024 to Might 29, 2024, the closing bid worth of the Firm’s ADSs had been at $1.00 per share or higher. Accordingly, the Firm has regained compliance with Nasdaq Itemizing Rule 5450(a)(1) and the matter is now closed.
About Burning Rock
Burning Rock Biotech Restricted (NASDAQ: BNR and LSE: BNR), whose mission is to protect life through science, focuses on the applying of subsequent technology sequencing (NGS) expertise within the discipline of precision oncology. Its enterprise consists of i) NGS-based remedy choice testing for late-stage most cancers sufferers, and ii) most cancers early detection, which has moved past proof-of-concept R&D into the medical validation stage.
For extra details about Burning Rock, please go to: ir.brbiotech.com.
Protected Harbor Assertion
This press launch comprises forward-looking statements. These statements represent forward-looking statements inside the that means of Part 21E of the Securities Change Act of 1934, as amended, and as outlined within the U.S. Non-public Securities Litigation Reform Act of 1995. These forward-looking statements will be recognized by terminology reminiscent of will, expects, anticipates, future, intends, plans, believes, estimates, goal, assured and related statements. Burning Rock can also make written or oral forward-looking statements in its periodic studies to the SEC, in its annual report back to shareholders, in press releases and different written supplies and in oral statements made by its officers, administrators or staff to 3rd events. Statements that aren’t historic info, together with statements about Burning Rock’s beliefs and expectations, are forward-looking statements. Such statements are based mostly upon administration’s present expectations and present market and working situations, and relate to occasions that contain recognized or unknown dangers, uncertainties and different components, all of that are troublesome to foretell and plenty of of that are past Burning Rock’s management. Ahead-looking statements contain dangers, uncertainties and different components that would trigger precise outcomes to vary materially from these contained in any such statements. All data supplied on this press launch is as of the date of this press launch, and Burning Rock doesn’t undertake any obligation to replace any forward-looking assertion because of new data, future occasions or in any other case, besides as required underneath relevant legislation.
Contact: IR@brbiotech.com
Supply: Burning Rock Biotech Restricted
